The 1‑year return of +53.2%—nearly double the S&P's 29.5% gain—signals that RLJ has delivered superior compounding, positioning it as an attractive income‑plus growth play for investors seeking both yield and capital appreciation.
The negative long‑term annuities (e.g., -4.7% over five years) reveal that while RLJ outperforms the index, absolute returns remain modest; a sustained rise in financing costs or prolonged tourism downturn could erode cash flow and push total return deeper into negative territory.
Despite strong institutional backing, the overbought RSI (86.7) combined with a modest recent pullback risk indicates that smart money may be pricing in optimistic growth assumptions; a 5% correction could test whether institutions maintain their positions or begin to trim exposure, which would amplify downside pressure.
The three‑year revenue CAGR of 4.2% stands out as a positive signal because it demonstrates that RLJ can generate incremental top‑line growth through portfolio expansion and lease escalations, which could re‑accelerate once occupancy rebounds post‑pandemic.
The negative gross margin (‑0.9%) quantifies a structural cost overrun; if occupancy and ADRs do not improve sufficiently to offset these costs, RLJ may face pressure on operating cash flow, jeopardizing its ability to service debt and maintain dividend payouts.
The profit‑margin plunge to 2.1%—a more than 90% decline YoY—is the single most damaging factor for ROE, underscoring a fundamental earnings weakness that outweighs any leverage benefits and raises concerns about sustainable cash generation.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | 1.3 | 2.1 | 0.28 | 2.19 | 33.3 | 2.8 | 0.6 |
| 2024 | 3.0 | 5.0 | 0.28 | 2.14 | 39.6 | 3.2 | 1.4 |
| 2023 | 3.3 | 5.8 | 0.27 | 2.11 | 27.7 | 3.3 | 1.6 |
| 2022 | 1.7 | 3.5 | 0.24 | 2.06 | 21.0 | 2.5 | 0.8 |
| 2021 | -12.7 | -38.8 | 0.15 | 2.15 | -6.9 | -1.0 | -5.9 |
| 2020 | -15.2 | -87.0 | 0.08 | 2.11 | -7.9 | -1.3 | -7.2 |
| 2019 | 4.0 | 8.2 | 0.27 | 1.83 | 51.6 | 8.0 | 2.2 |
| 2018 | 5.5 | 10.8 | 0.29 | 1.73 | 4.6 | 4.5 | 3.2 |
| 2017 | 2.1 | 5.6 | 0.20 | 1.92 | 2.8 | 2.8 | 1.1 |
| 2016 | 9.0 | 17.3 | 0.29 | 1.81 | 5.8 | 5.7 | 5.0 |
| 2015 | 10.0 | 19.2 | 0.29 | 1.82 | 5.4 | 5.4 | 5.5 |
The reliance on high‑leverage to sustain a 2.19 equity multiplier creates a risk that a modest rise in borrowing costs (e.g., a 100 bps increase) would cut net operating profit by approximately $12 million, potentially pulling ROIC below the 30% threshold and weakening cash flow resilience.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 1282 | 0 | 8 | 33 | 38 | -30 |
| 2024 | 1302 | 0 | 7 | 34 | 57 | -51 |
| 2023 | 1355 | 0 | 7 | 37 | 58 | -51 |
| 2022 | 1522 | 0 | 12 | 42 | 68 | -57 |
| 2021 | 2392 | 0 | 14 | 67 | 94 | -80 |
| 2020 | 4413 | 0 | 10 | 112 | 127 | -117 |
| 2019 | 1362 | 0 | 9 | 34 | 62 | -53 |
| 2018 | 1245 | 19 | 11 | 1115 | 61 | -31 |
| 2017 | 1829 | 29 | 16 | 1558 | 91 | -46 |
| 2016 | 1266 | 33 | 8 | 1060 | 67 | -26 |
| 2015 | 1278 | 28 | 8 | 1180 | 64 | -28 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $4742M | $2559M | $2170M | $2315M | $1905M | $410M | $499M | $244M |
| 2024 | $4884M | $2586M | $2285M | $2339M | $1929M | $410M | $498M | $246M |
| 2023 | $4919M | $2569M | $2337M | $2343M | $1827M | $517M | $640M | $225M |
| 2022 | $4978M | $2550M | $2415M | $2335M | $1853M | $481M | $654M | $215M |
| 2021 | $5149M | $2735M | $2398M | $2532M | $1867M | $665M | $778M | $203M |
| 2020 | $5617M | $2930M | $2667M | $2710M | $1811M | $900M | $981M | $219M |
| 2019 | $5851M | $2625M | $3202M | $2317M | $1434M | $882M | $1025M | $308M |
| 2018 | $6005M | $2508M | $3474M | $2203M | $1883M | $320M | $504M | $277M |
| 2017 | $6795M | $3225M | $3547M | $2880M | $2294M | $586M | $789M | $308M |
| 2016 | $4023M | $1788M | $2222M | $1583M | $1126M | $457M | $610M | $182M |
| 2015 | $3980M | $1780M | $2183M | $1583M | $1449M | $134M | $247M | $175M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $244M | $-57M | $-178M | $-126M | $117M | $-32M | $-91M |
| 2024 | $285M | $-276M | $-132M | $285M | $-31M | $-70M | |
| 2023 | $315M | $-135M | $-161M | $315M | $-80M | $-49M | |
| 2022 | $257M | $-136M | $-298M | $-124M | $257M | $-61M | $-13M |
| 2021 | $43M | $-25M | $-239M | $-48M | $-5M | $-3M | $-7M |
| 2020 | $-169M | $-67M | $243M | $-73M | $-242M | $-64M | $-61M |
| 2019 | $397M | $530M | $-385M | $397M | $-125M | $-228M | |
| 2018 | $395M | $277M | $-946M | $-0M | $395M | $-25M | $-231M |
| 2017 | $261M | $65M | $-190M | $-0M | $260M | $-6M | $-170M |
| 2016 | $331M | $173M | $-182M | $-0M | $331M | $-19M | $-164M |
| 2015 | $329M | $-38M | $-419M | $-1M | $328M | $-237M | $-170M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net